Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168687 · ClinicalTrials.gov registry record · NA
Effects of Levetiracetam (Keppra) on Alcohol Consumption
A NA study of Alcohol Abuse and Drug Abuse, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT01168687 is a NA study of Alcohol Abuse and Drug Abuse that has completed, run by University of California, San Francisco. The registered enrollment target is 46 participants, below the 712-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01168687, a NA study of Alcohol Abuse and Drug Abuse, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goals of this study are to (1) expand knowledge about interactions of levetiracetam with alcohol by assessing the effects of levetiracetam compared to placebo in moderate and heavy social alcohol users and (2) to test the AccuswayTM platform as a tool to measure postural control (which has been used as a marker of intoxication) and the effects of levetiracetam on postural control.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Levetiracetam (Keppra)
Study Locations (1)
California
- Children's Hospital Oakland Research Institute- CRC - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01168687
The ClinicalTrials.gov registry entry for NCT01168687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 712-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01168687 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01168687 about?
NCT01168687 is a clinical study titled "Effects of Levetiracetam (Keppra) on Alcohol Consumption". The overall goals of this study are to (1) expand knowledge about interactions of levetiracetam with alcohol by assessing the effects of levetiracetam compared to placebo in moderate and heavy social alcohol users and (2) to test the AccuswayTM platform as a tool to measure postural control (which h...
What is the current status of trial NCT01168687?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2008-11. Estimated completion is 2010-11.
What conditions does trial NCT01168687 study?
This clinical trial studies the following conditions: Alcohol Abuse, Drug Abuse.
What interventions are being tested in trial NCT01168687?
The interventions under investigation include: Placebo (DRUG), Levetiracetam (Keppra) (DRUG).
Who is sponsoring clinical trial NCT01168687?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01168687 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.